Klaus R DrVeitinger's Net Worth
$6.56 Million
Who is Klaus R DrVeitinger?
Klaus R DrVeitinger has an estimated net worth of $6.56 Million. This is based on reported shares across multiple companies, which include Relypsa Inc, INTERCEPT PHARMACEUTICALS INC, Tricida, Inc., scPharmaceuticals Inc., and BONE CARE INTERNATIONAL INC.
SEC CIK
Klaus R DrVeitinger's CIK is 0001283972
Past Insider Trading and Trends
2014 was Klaus R DrVeitinger's most active year for acquiring shares with 23 total transactions. Klaus R DrVeitinger's most active month to acquire stocks was the month of May. 2014 was Klaus R DrVeitinger's most active year for disposing of shares, totalling 58 transactions. Klaus R DrVeitinger's most active month to dispose stocks was the month of January. 2004 saw Klaus R DrVeitinger paying a total of $482,000.00 for 20,000 shares, this is the most they've acquired in one year. In 2005 Klaus R DrVeitinger cashed out on 93,808 shares for a total of $2,132,889.52, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Relypsa Inc No price found
InvestorKlaus R DrVeitinger owns 2,712 units of Common Stock.acquired a total of 66,884 shares in Relypsa Inc at a cost of $288,623.19, Klaus also disposed a total of 64,172 shares of Relypsa Inc equalling to $1,955,060.30.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$20.01 | -$187,284.23 | 2.71K |
Scheduled
|
May 11
| ||
Form 4
|
—
|
0
|
$19.66 | -$183,083.98 | 2.71K |
Scheduled
|
Apr 10
| ||
Form 4
|
—
|
0
|
$21.51 | -$200,192.75 | 2.71K |
Scheduled
|
Mar 10
| ||
Form 4
|
—
|
0
|
$18.38 | -$160,231.38 | 2.71K |
Scheduled
|
Feb 10
| ||
Form 4
|
—
|
0
|
$18.49 | -$161,460.52 | 2.71K |
Scheduled
|
Jan 12
| ||
Form 4
|
—
|
0
|
$18.40 | -$389,796.02 | 2.71K |
Scheduled
|
Dec 10 - Dec 12
| ||
Form 4
|
—
|
0
|
$13.58 | -$59,511.90 | 2.71K |
Scheduled
|
Nov 20
| ||
Form 4
|
—
|
0
|
$12.36 | -$38,519.00 | 2.71K |
Scheduled
|
Nov 10
| ||
Form 4
|
—
|
0
|
$12.00 | -$36,718.20 | 2.71K |
Scheduled
|
Oct 10
| ||
Form 4
|
—
|
0
|
$13.83 | -$76,474.45 | 2.71K |
Scheduled
|
Sep 10
| ||
Form 4
|
—
|
0
|
$16.19 | -$96,186.86 | 2.71K |
Scheduled
|
Aug 11
| ||
Form 4
|
—
|
0
|
$13.89 | -$76,977.82 | 2.71K |
Scheduled
|
Jul 10
| ||
Form 4
|
∞
| 2.71K |
—
|
—
| 2.71K |
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INTERCEPT PHARMACEUTICALS INC (ICPT) No price found
InvestorKlaus R DrVeitinger owns 2,816 units of Common stock. In the year 2012 Klaus R DrVeitinger filed a total of 28 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +30.01% | 650 |
—
|
—
| 2.82K |
Nov 24
| |||
Form 4
|
—
|
0
|
$109.88 | -$176,750.00 | 2.17K |
Scheduled
|
Nov 10
| ||
Form 4
|
—
|
0
|
$109.88 | -$88,375.00 | 2.17K |
Scheduled
|
Sep 9
| ||
Form 4
|
—
|
0
|
$141.34 | -$119,835.00 | 2.17K |
Scheduled
|
Aug 3
| ||
Form 4
|
—
|
0
|
$129.86 | -$84,733.61 | 2.17K |
Scheduled
|
Jun 10
| ||
Form 4
|
—
|
0
|
$150.29 | -$100,710.33 | 2.17K |
Scheduled
|
May 11
| ||
Form 4
|
—
|
0
|
$146.80 | -$97,984.60 | 2.17K |
Scheduled
|
Apr 10
| ||
Form 4
|
—
|
0
|
$141.78 | -$94,058.27 | 2.17K |
Scheduled
|
Mar 10
| ||
Form 4
|
—
|
0
|
$122.00 | -$127,032.00 | 2.17K |
Scheduled
|
Feb 24
| ||
Form 4
|
—
|
0
|
$108.51 | -$40,546.66 | 2.17K |
Scheduled
|
Feb 10
| ||
Form 4
|
—
|
0
|
$85.76 | -$29,942.83 | 2.17K |
Scheduled
|
Jan 12
| ||
Form 4
|
—
|
0
|
$82.83 | -$28,579.78 | 2.17K |
Scheduled
|
Dec 10
| ||
Form 4
|
—
|
0
|
$98.73 | -$35,986.85 | 2.17K |
Scheduled
|
Nov 10
| ||
Form 4
|
—
|
0
|
$122.58 | -$79,040.65 | 2.17K |
Scheduled
|
Oct 10
| ||
Form 4
|
—
|
0
|
$151.00 | -$101,269.00 | 2.17K |
Scheduled
|
Sep 10
| ||
Form 4
|
—
|
0
|
$183.56 | -$102,421.92 | 2.17K |
Scheduled
|
Aug 12
| ||
Form 4
| +7.98% | 160 |
$130.11 | -$132,487.99 | 2.17K |
Scheduled
|
Aug 9 - Aug 11
| ||
Form 4
| +12.70% | 226 |
—
|
—
| 2.01K |
Jul 17
| |||
Form 4
|
—
|
0
|
$120.33 | -$77,281.54 | 1.78K |
Scheduled
|
Jul 10
| ||
Form 4
| -22.00% | -502.00 |
$249.78 | -$206,564.28 | 1.78K |
Scheduled
|
May 7 - May 9
| ||
Form 4
| +7.64% | 162 |
$377.72 | -$61,190.25 | 2.28K |
Scheduled
|
Feb 9 - Feb 10
| ||
Form 4
| +8.33% | 163 |
$48.93 | -$7,927.22 | 2.12K |
Scheduled
|
Nov 9 - Nov 11
| ||
Form 4
| -25.53% | -671.00 |
$73.42 | -$49,261.50 | 1.96K |
Scheduled
|
Oct 1
| ||
Form 4
| +14.11% | 325 |
—
|
—
| 2.63K |
Aug 9
| |||
Form 4
| +254.85% | 1.65K |
—
|
—
| 2.3K |
May 7 - May 9
| |||
Form 4
|
∞
| 649 |
—
|
—
| 649 |
Apr 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tricida, Inc. No price found
InvestorKlaus R DrVeitinger owns 27,584 units of Common Stock. From 2018 to 2022 Klaus R DrVeitinger acquired a total of 77,835 shares in Tricida, Inc. at a cost of $40,200.80, Klaus also disposed a total of 50,251 shares of Tricida, Inc. equalling to $1,549,072.73.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +146.70% | 16.4K |
—
|
—
| 27.58K |
Jun 10
| |||
Form 4
| +13.72% | 5.67K |
—
|
—
| 46.98K |
Jun 11
| |||
Form 4
| -2.37% | -3.50K |
$19.84 | -$202,702.50 | 144.2K |
Scheduled
|
Nov 1
| ||
Form 4
| -2.31% | -3.50K |
$18.55 | -$189,175.00 | 147.7K |
Scheduled
|
Oct 25
| ||
Form 4
| -1.82% | -2.80K |
$16.11 | -$130,827.59 | 151.2K |
Scheduled
|
Sep 26
| ||
Form 4
| -1.79% | -2.80K |
$16.98 | -$138,166.00 | 154K |
Scheduled
|
Aug 26
| ||
Form 4
| -1.75% | -2.80K |
$16.21 | -$131,698.00 | 156.8K |
Scheduled
|
Jul 25
| ||
Form 4
| -1.48% | -2.39K |
$18.55 | -$125,868.60 | 159.6K |
Scheduled
|
Jul 5
| ||
Form 4
| -3.58% | -6.01K |
$18.85 | -$333,636.12 | 162K |
Scheduled
|
Jul 3
| ||
Form 4
| +4.76% | 1.88K |
—
|
—
| 41.31K |
May 31
| |||
Form 4
| -21.02% | -44.20K |
$17.49 | -$2,248,896.00 | 166.12K |
Scheduled
|
Mar 28
| ||
Form 4
| -3.66% | -8.00K |
$12.32 | -$282,760.00 | 210.32K |
Scheduled
|
Mar 26
| ||
Form 4
| -3.53% | -8.00K |
$11.70 | -$267,960.00 | 218.32K |
Scheduled
|
Feb 25
| ||
Form 4
| -1.74% | -4.00K |
$10.56 | -$120,280.00 | 226.32K |
Scheduled
|
Jan 28
| ||
Form 4
| -1.71% | -4.00K |
$10.83 | -$123,580.00 | 230.32K |
Scheduled
|
Jan 25
| ||
Form 4
| -0.61% | -1.44K |
$12.26 | -$56,975.11 | 234.32K |
Scheduled
|
Dec 27
| ||
Form 4
| -2.71% | -6.56K |
$12.89 | -$242,452.38 | 235.76K |
Scheduled
|
Dec 26
| ||
Form 4
| +10.14% | 3.63K |
—
|
—
| 39.44K |
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
scPharmaceuticals Inc. (SCPH) Snapshot price: $5.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BONE CARE INTERNATIONAL INC No price found
InvestorKlaus R DrVeitinger used to own units in BCII Common Stock but no longer holds any shares there. In the year 2004 Klaus R DrVeitinger filed a total of 4 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -46.90K |
$33.00 | -$1,547,832.00 |
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 23
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||